XML 74 R63.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Segment Information        
Net Sales to External Customers $ 7,979 $ 7,767 $ 15,514 $ 15,157
Operating Earnings 1,206 882 1,945 1,490
Amortization of intangible assets (483) (562) (969) (1,146)
Earnings from continuing operations before tax 1,102 777 $ 1,734 1,208
Annual share-based awards recognized in first quarter (as a percent)     50.00%  
Established Pharmaceutical Products        
Segment Information        
Net Sales to External Customers 1,108 1,129 $ 2,100 2,173
Nutritional Products        
Segment Information        
Net Sales to External Customers 1,875 1,858 3,667 3,614
Diagnostic Products        
Segment Information        
Net Sales to External Customers 1,905 1,873 3,746 3,710
Cardiovascular and Neuromodulation Products        
Segment Information        
Net Sales to External Customers 2,473 2,421 4,802 4,744
Other        
Segment Information        
Net Sales to External Customers 618 486 1,199 916
Total Reportable Segments        
Segment Information        
Net Sales to External Customers 7,361 7,281 14,315 14,241
Operating Earnings 1,871 1,882 3,538 3,581
Total Reportable Segments | Established Pharmaceutical Products        
Segment Information        
Net Sales to External Customers 1,108 1,129 2,100 2,173
Operating Earnings 214 208 373 375
Total Reportable Segments | Nutritional Products        
Segment Information        
Net Sales to External Customers 1,875 1,858 3,667 3,614
Operating Earnings 447 424 827 789
Total Reportable Segments | Diagnostic Products        
Segment Information        
Net Sales to External Customers 1,905 1,873 3,746 3,710
Operating Earnings 466 489 900 932
Total Reportable Segments | Cardiovascular and Neuromodulation Products        
Segment Information        
Net Sales to External Customers 2,473 2,421 4,802 4,744
Operating Earnings 744 761 1,438 1,485
Corporate functions        
Segment Information        
Corporate functions and benefit plans costs (99) (140) (201) (292)
Reconciling items        
Segment Information        
Non-reportable segments 173 125 327 217
Net interest expense (146) (189) (294) (388)
Share-based compensation (a) (114) (101) (340) (313)
Amortization of intangible assets (483) (562) (969) (1,146)
Other, net (b) $ (100) $ (238) $ (327) $ (451)